🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, multicenter, double-blind, placebo- controlled parallel-group...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-10-31
Trial ID
NCT03226392
This study will characterize the pharmacokinetics (PK) of QAW039 after a si...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-31
Trial ID
NCT03048448
Treatments Being Tested
The overall purpose of this study was to determine the efficacy of fevipipr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2018-12-13
Trial ID
NCT03629249
Treatments Being Tested
This study was a 2-treatment period, randomized, multicenter parallel-group...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2017-03-21
Trial ID
NCT03052517
Treatments Being Tested
The aim of this study is to draw blood from patients with well-defined atop...
Status
Completed
Location
Fraunhofer ITEM im CRC
Start Date
2018-08-16
Trial ID
NCT03665701
Treatments Being Tested
This study aimed to determine the efficacy and safety of QAW039 150 mg and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-12-11
Trial ID
NCT02555683
This study aimed to determine the efficacy and safety of QAW039 and QAW039 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-12-03
Trial ID
NCT02563067
The purpose of this study was to assess the pharmacokinetics (PK) of fevipi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-05-01
Trial ID
NCT03650400
Treatments Being Tested
This study will assess the safety, efficacy and pharmacokinetics of QAW039 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-11
Trial ID
NCT01253603